|
1
|
Zamay TN, Zamay GS, Kolovskaya OS, Zukov
RA, Petrova MM, Gargaun A, Berezovski MV and Kichkailo AS: Current
and prospective protein biomarkers of lung cancer. Cancers.
9:E1552017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fiorentino FP, Macaluso M, Miranda F,
Montanari M, Russo A, Bagella L and Giordano A: CTCF and BORIS
regulate Rb2/p130 gene transcription: A novel mechanism and
a new paradigm for understanding the biology of lung cancer. Mol
Cancer Res. 9:225–233. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Blandin Knight S, Crosbie PA, Balata H,
Chudziak J, Hussell T and Dive C: Progress and prospects of early
detection in lung cancer. Open Biol. 7:1700702017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ren G, Esposito M and Kang Y: Bone
metastasis and the metastatic niche. J Mol Med. 93:1203–1212. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zang L, Ma M, Hu J, Qiu H, Huang B and Chu
T: The effects of lung and prostate cancer bone metastasis on serum
osteoprotegerin levels: A meta-analysis. Sci Rep. 5:183242015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Siegfried JM and Stabile LP: Estrongenic
steroid hormones in lung cancer. Semin Oncol. 41:5–16. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chlebowski RT, Schwartz AG, Wakelee H,
Anderson GL, Stefanick ML, Manson JE, Rodabough RJ, Chien JW,
Wactawski-Wende J, Gass M and Women's Health Initiative
Investigators: Oestrogen plus progestin and lung cancer in
postmenopausal women (Women's Health Initiative trial): A post-hoc
analysis of a randomised controlled trial. Lancet. 374:1243–1251.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sims NA, Clément-Lacroix P, Minet D,
Fraslon-Vanhulle C, Gaillard-Kelly M, Resche-Rigon M and Baron R: A
functional androgen receptor is not sufficient to allow estradiol
to protect bone after gonadectomy in estradiol receptor-deficient
mice. J Clin Invest. 111:1319–1327. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hsu LH, Liu KJ, Tsai MF, Wu CR, Feng AC,
Chu NM and Kao SH: Estrogen adversely affects the prognosis of
patients with lung adenocarcinoma. Cancer Sci. 106:51–59. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kawai H, Ishii A, Washiya K, Konno T, Kon
H, Yamaya C, Ono I, Minamiya Y and Ogawa J: Estrogen receptor alpha
and beta are prognostic factors in non-small cell lung cancer. Clin
Cancer Res. 11:5084–5089. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Allred DC, Harvey JM, Berardo M and Clark
GM: Prognostic and predictive factors in breast cancer by
immunohistochemical analysis. Mod Pathol. 11:155–168.
1998.PubMed/NCBI
|
|
12
|
Liu Y, Yan X, Liu N, Zhou J, Liu J, Pang
H, Cao J, Liu Y, Wang Y, Liu L and Zhang H: Lentivirus-delivered
ZEB-1 small interfering RNA inhibits lung adenocarcinoma cell
growth in vitro and in vivo. J Cancer Res Clin Oncol.
138:1329–1338. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Andersson S, Sundberg M, Pristovsek N,
Ibrahim A, Jonsson P, Katona B, Clausson CM, Zieba A, Ramström M,
Söderberg O, et al: Insufficient antibody validation challenges
oestrogen receptor beta research. Nat Commun. 8:158402017.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hsu LH, Chu NM and Kao SH: Estrogen,
estrogen receptor and lung cancer. Int J Mol Sci. 18:17132017.
View Article : Google Scholar :
|
|
15
|
Mah V, Marquez D, Alavi M, Maresh EL,
Zhang L, Yoon N, Horvath S, Bagryanova L, Fishbein MC, Chia D, et
al: Expression levels of estrogen receptor beta in conjunction with
aromatase predict survival in non-small cell lung cancer. Lung
Cancer. 74:318–325. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Luo Z, Wu R, Jiang Y, Qiu Z, Chen W and Li
W: Overexpression of estrogen receptor beta is a prognostic marker
in non-small cell lung cancer: A meta-analysis. Int J Clin Exp Med.
8:8686–8697. 2015.PubMed/NCBI
|
|
17
|
Fan S, Liao Y, Liu C, Huang Q, Liang H, Ai
B, Fu S and Zhou S: Estrogen promotes tumor metastasis via estrogen
receptor beta-mediated regulation of matrix-metalloproteinase-2 in
non-small cell lung cancer. Oncotarget. 8:56443–56459.
2017.PubMed/NCBI
|
|
18
|
Warner M and Gustafsson JA: The role of
estrogen receptor beta (ERbeta) in malignant diseases--a new
potential target for antiproliferative drugs in prevention and
treatment of cancer. Biochem Biophys Res Commun. 396:63–66. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Prusty BK and Das BC: Constitutive
activation of transcription factor AP-1 in cervical cancer and
suppression of human papillomavirus (HPV) transcription and AP-1
activity in HeLa cells by curcumin. Int J Cancer. 113:951–960.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhao XZ, Liu Y, Zhou LJ, Wang ZQ, Wu ZH
and Yang XY: Role of estrogen in lung cancer based on the estrogen
receptor-epithelial mesenchymal transduction signaling pathways.
OncoTargets Ther. 8:2849–2863. 2015. View Article : Google Scholar
|
|
21
|
Valastyan S and Weinberg RA: Tumor
metastasis: Molecular insights and evolving paradigms. Cell.
147:275–292. 2011. View Article : Google Scholar : PubMed/NCBI
|
